Gómez-Álvarez, M.; Bueno-Fernandez, C.; Rodríguez-Eguren, A.; Francés-Herrero, E.; Agustina-Hernández, M.; Faus, A.; Gisbert-Roca, F.... (2024). Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives. Advanced Healthcare Materials (Online). 13(11):1-19. https://doi.org/10.1002/adhm.202303838
Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/205869
Título:
|
Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives
|
Autor:
|
Gómez-Álvarez, María
Bueno-Fernandez, Clara
Rodríguez-Eguren, Adolfo
Francés-Herrero, Emilio
Agustina-Hernández, Marcos
Faus, Amparo
Gisbert-Roca, Fernando
Martínez-Ramos, Cristina
Galán, Amparo
Pellicer, Antonio
Ferrero, Hortensia
Cervelló, Irene
|
Fecha difusión:
|
|
Resumen:
|
[EN] The endometrium plays a vital role in fertility, providing a receptive environment for embryo implantation and development. Understanding the endometrial physiology is essential for developing new strategies to improve ...[+]
[EN] The endometrium plays a vital role in fertility, providing a receptive environment for embryo implantation and development. Understanding the endometrial physiology is essential for developing new strategies to improve reproductive healthcare. Human endometrial organoids (hEOs) are emerging as powerful models for translational research and personalized medicine. However, most hEOs are cultured in a 3D microenvironment that significantly differs from the human endometrium, limiting their applicability in bioengineering. This study presents a hybrid endometrial-derived hydrogel that combines the rigidity of PuraMatrix (PM) with the natural scaffold components and interactions of a porcine decellularized endometrial extracellular matrix (EndoECM) hydrogel. This hydrogel provides outstanding support for hEO culture, enhances hEO differentiation efficiency due to its biochemical similarity with the native tissue, exhibits superior in vivo stability, and demonstrates xenogeneic biocompatibility in mice over a 2-week period. Taken together, these attributes position this hybrid endometrial-derived hydrogel as a promising biomaterial for regenerative treatments in reproductive medicine.
[-]
|
Palabras clave:
|
Endometrium
,
Embryo implantation
,
Endometrial extracellular matrix
,
Hybrid endometrial-derived hydrogel
,
Reproductive medicine
|
Derechos de uso:
|
Reconocimiento - No comercial - Sin obra derivada (by-nc-nd)
|
Fuente:
|
Advanced Healthcare Materials (Online). (eissn:
2192-2659
)
|
DOI:
|
10.1002/adhm.202303838
|
Editorial:
|
Wiley-VCH
|
Versión del editor:
|
https://doi.org/10.1002/adhm.202303838
|
Código del Proyecto:
|
info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00305/ES/ORGANOIDES HUMANOS COMO MODELOS DEL TRACTO REPRODUCTIVO FEMENINO SANO UTILIZANDO SOPORTES NATIVOS DE BIOINGENIERIA Y SUS APLICACIONES PRECLINICAS EN EL CAMPO DE LA MEDICINA GINECOLOGICA./
...[+]
info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F00305/ES/ORGANOIDES HUMANOS COMO MODELOS DEL TRACTO REPRODUCTIVO FEMENINO SANO UTILIZANDO SOPORTES NATIVOS DE BIOINGENIERIA Y SUS APLICACIONES PRECLINICAS EN EL CAMPO DE LA MEDICINA GINECOLOGICA./
info:eu-repo/grantAgreement/UPV-VIN//PAID-10-22//El papel de los estímulos mecánicos, eléctricos, magnéticos y biológicos en la regeneración del sistema nervioso
/
info:eu-repo/grantAgreement/GVA//CIAPOT%2F2022%2F29/
info:eu-repo/grantAgreement/GVA//CIPROM%2F2021%2F058/
info:eu-repo/grantAgreement/ISCIII//CP19%2F00149/
info:eu-repo/grantAgreement/MCIU//MS21-142/
info:eu-repo/grantAgreement/MCIU//FPU20%2F00251/
info:eu-repo/grantAgreement/MCIU//FPU19%2F04850/
info:eu-repo/grantAgreement/MCIU//FPU18%2F06327/
info:eu-repo/grantAgreement/ESF//CD20%2F00120/
[-]
|
Agradecimientos:
|
This work was supported by Instituto de Salud Carlos III and co-founded by the European Union (Fondo Social Europeo), «El FSE invierte en tu futuro» (PI21/00305 [IC]) through the Miguel Servet Program (CP20/00120 [HF]; ...[+]
This work was supported by Instituto de Salud Carlos III and co-founded by the European Union (Fondo Social Europeo), «El FSE invierte en tu futuro» (PI21/00305 [IC]) through the Miguel Servet Program (CP20/00120 [HF]; CP19/00149 [IC]), Ministerio de Universidades (FPU20/00251 [MGÁ], FPU19/04850 [ARE], FPU18/06327 [EFH], MS21-142 [CBF]), Generalitat Valenciana (CIAPOT/2022/29 [MAH], CIPROM/2021/058 [AP and IC]), and Vicerrectorado de Investigación de la Universitat Politècnica de València (PAID-10-22 [FGR]).
[-]
|
Tipo:
|
Artículo
|